Wells Fargo
XERS icon

Wells Fargo’s Xeris Biopharma Holdings XERS Stock Holding History

Wells Fargo’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-614,000
Closed -$401K – 7458
2020
Q4 		$401K Hold
614,000
– – ﹤0.01% 4677
2020
Q3 		$1.45M Buy
+614,000
New +$2.46M ﹤0.01% 3579

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Wells Fargo's XERS Position: Q2 2026 in Review

Wells Fargo increased its Xeris Biopharma Holdings (XERS) stake by 170% in Q2 2026, buying an estimated $633K and bringing the position to 157,487 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #3954.

Wells Fargo first reported a position in XERS in Q3 2018 and has held it in 32 quarters since. The position peaked at $1.34M in Q4 2025. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Wells Fargo held 157,487 shares of Xeris Biopharma Holdings worth $1.25M as of Q2 2026.
  • Wells Fargo bought 99,180 Xeris Biopharma Holdings shares in Q2 2026, an estimated $633K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #3954 holding.
  • Wells Fargo first reported a position in Xeris Biopharma Holdings in Q3 2018 and has held it in 32 quarters since.
  • Wells Fargo's Xeris Biopharma Holdings position peaked at $1.34M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.